THY1 and breast carcinoma: Similarly, the expression of GD2, a reported surface marker of breast cancer stem cells, strongly (r ∼ 0.7) correlated with the mesenchymal marker CD90 and only on the surface of tumor cells (FlowSOM.Pop4, Fig. 4D).